CLINICAL_TRIALS
trial_result
· 2023-04-04
Clinical Trial Update: NISCI - Nogo Inhibition in Spinal Cord Injury [Phase 2]
Summary
Phase 2 clinical trial update for NISCI investigating Nogo inhibition in acute spinal cord injury has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Zurich | Conditions: Spinal Cord Injury, Acute | Phase 2 | Status: COMPLETED